Display Settings:

Format

Send to:

Choose Destination
    Int J Clin Pract. 2005 Sep;59(9):1082-7.

    HIV and hepatitis C co-infection.

    Source

    Department of HIV and GU Medicine, The Chelsea and Westminster Hospital, London, UK.

    Abstract

    HIV/HCV co-infection is emerging as a major cause of morbidity and mortality in the 21st century. This editorial reviews the prevalence of co-infection, the factors involved in acquisition of HCV, and the influence of co-infection on disease progression. We examine the results of the major co-infection trials including APRICOT, ACTG 5071 and RIBAVIC. These trials, in association with emerging evidence for future therapies currently undergoing investigation, have led to increased hope of treatment success in co-infected individuals.

    PMID:
    16115185
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk